ARCHIVES

PSA Velocity Poor Predictor Of Prostate Cancer Occurrence

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

Ohio Plans To Build Four New Cancer Centers With $140 Million Bond Issue If Voters Approve

February 21, 1975

Review Of NCI Intramural Program Offers Over 60 Recommendations For Change

July 7, 1995

Healy Attacks Scripps-Sandoz Research Deal, Rep. Wyden Asks For HHS Investigation

March 19, 1993

HPV-Positive Women Over 30 Should Be Retested Within Two Years

September 30, 2011

NCI Faces Major Cuts On Gramm-Rudman Sequestration; Grants, Centers, Trials Slashed

November 3, 1989